Generate Biomedicines Begins IPO Push With Major Collaboration Deals

Generate Biomedicines’ IPO aims to fund Phase 3 GB-0895 for severe asthma/COPD and expand its pipeline. Learn more about GENB ...
FierceBiotech

Generate raises $273M—$100M less than previous round—but a huge bounty

Flagship Pioneering-founded Generate Biomedicines is tacking on a gigantic $273 million in series C funds, though the haul didn't reach the heights of the biotech’s previous $370 million raise back in ...
pharmaphorum

AI firm Generate signs $1bn discovery deal with Novartis

Flagship Pioneering-backed artificial intelligence start-up Generate:Biomedicines has attracted another big pharma partnership, this time with Novartis. The wide-ranging deal, worth up to $1 billion, ...